Suppr超能文献

二甲双胍可保护 ARPE-19 细胞免受糖基化终产物诱导的氧化应激。

Metformin Protects ARPE-19 Cells from Glyoxal-Induced Oxidative Stress.

机构信息

Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Department of Regenerative Medicine, And Department of Pharmacology, Tongji University School of Medicine, Shanghai, China.

Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai, China.

出版信息

Oxid Med Cell Longev. 2020 Jul 9;2020:1740943. doi: 10.1155/2020/1740943. eCollection 2020.

Abstract

The protective effects and mechanisms of metformin against oxidative stress were evaluated both and . ARPE-19 cells comprised the normal group, the glyoxal-treated group (0.5 mM glyoxal), and the glyoxal+metformin group (0.5 mM glyoxal and 0.1 mM metformin). In the model, differences in cell viability, ROS production, NO products, cellular apoptosis, and the expressions of phospho-AMPK, total-AMPK, Sirt1, Nrf2, TXNIP, ZO-1, and Occludin were assessed. In the glyoxal-treated group, cell viability and NO production were decreased, while ROS production and cell apoptosis were increased ( < 0.05), compared with the control group. These changes were prevented by metformin treatment. Protein expressions of phospho-AMPK, Sirt1, TXNIP, ZO-1, and Occludin, but not Nrf2, were decreased significantly in the glyoxal-treated group compared to normal controls. Metformin treatment significantly increased the above protein expressions and slightly increased TXNIP expression. Immunofluorescence showed that metformin prevented the glyoxal-induced, disorganized tight junctions in ARPE-19 cells. To confirm metformin's protection, Sprague-Dawley rats were injected intravenously with sodium iodate (SI) to induce oxidative stress in the retinal pigment epithelium (RPE). Metformin was then delivered intraperitoneally or intravitreally. One day and three days after SI and metformin treatments, the RPE-Bruch's membrane-choriocapillaris complex was isolated and immune-stained with ZO-1 antibodies. The morphology of the RPE showed enlarged cellular bodies and disorganized ZO-1 staining in SI-treated rats. Metformin treatment prevented these changes. The results indicated that metformin maintained the barrier functions of RPE cells both and . Metformin exerted its protection against oxidative stress possibly via activating AMPK/Sirt1 and increasing TXNIP. Metformin has been proposed as a candidate drug for age-related macular degeneration (AMD) by both preclinical and clinical studies. The cellular and animal models used in this study might be useful for the interpretation of the molecular mechanisms involved in the drug activity.

摘要

评估了二甲双胍对氧化应激的保护作用及其机制,分别为 和 。ARPE-19 细胞分为正常组、乙二醛处理组(0.5mM 乙二醛)和乙二醛+二甲双胍组(0.5mM 乙二醛和 0.1mM 二甲双胍)。在 模型中,评估了细胞活力、ROS 产生、NO 产物、细胞凋亡以及磷酸化-AMPK、总-AMPK、Sirt1、Nrf2、TXNIP、ZO-1 和 Occludin 的表达差异。在乙二醛处理组中,与对照组相比,细胞活力和 NO 产物降低,而 ROS 产生和细胞凋亡增加(<0.05)。二甲双胍治疗可预防这些变化。与正常对照组相比,乙二醛处理组中磷酸化-AMPK、Sirt1、TXNIP、ZO-1 和 Occludin 的蛋白表达明显降低,但 Nrf2 蛋白表达没有明显降低。二甲双胍治疗显著增加了上述蛋白表达,并且略微增加了 TXNIP 表达。免疫荧光显示,二甲双胍可防止 ARPE-19 细胞中乙二醛诱导的紧密连接排列紊乱。为了证实二甲双胍的保护作用,向 Sprague-Dawley 大鼠静脉注射碘酸钠(SI)以诱导视网膜色素上皮(RPE)中的氧化应激。然后通过腹膜内或玻璃体内给予二甲双胍。在 SI 和二甲双胍处理后的第 1 天和第 3 天,分离 RPE-布鲁赫膜-脉络膜毛细血管复合体并与 ZO-1 抗体免疫染色。在 SI 处理的大鼠中,RPE 的形态显示细胞体积增大且 ZO-1 染色排列紊乱。二甲双胍治疗可防止这些变化。结果表明,二甲双胍维持了 RPE 细胞的屏障功能,分别为 和 。二甲双胍通过激活 AMPK/Sirt1 和增加 TXNIP 发挥其抗氧化应激作用。二甲双胍已被临床前和临床研究提出作为治疗年龄相关性黄斑变性(AMD)的候选药物。本研究中使用的细胞和动物模型可能有助于解释药物活性涉及的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b9/7368933/bfd89dcf7b9d/OMCL2020-1740943.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验